Sign in

Raiees Andrabi

@raieesandrabi.bsky.social
55 followers 100 following 10 posts

Associate Professor @PennMedicine @Penn Viruses| Vaccines| Protein engineering| B cells| Antibodies| Glycans. Cricket enthusiast www.med.upenn.edu/apps/faculty/inde…

PostsRepliesMedia
Raiees Andrabi @raieesandrabi.bsky.social · 14/04/2026
Excited to share our new paper in @cp-immunity.bsky.social showing that "Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques" A promisingstep toward an HIV vaccine advancing soon to human clinical testing! Immunity www.cell.com/immunity/ful...
cell.com
Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques
Inducing broadly neutralizing antibodies (bnAbs) remains a challenge in HIV vaccine development. Mishra et al. show that an engineered germline-targeting HIV trimer, Q23-APEX-GT2, primes rare V2-apex ...
142
Reposted by Raiees Andrabi
Hensley Lab @scottehensley.bsky.social · 22/02/2026
Our preprint examining the specificity of human antibodies that cross-react with subclade K H3N2 viruses was posted this morning on medRxiv. These studies have implications on what vaccine strains should be selected for next year’s influenza season. 1/ www.medrxiv.org/content/10.6...
medrxiv.org
Mapping the specificity of H3N2 strain-specific and cross-reactive human neutralizing antibodies elicited by the 2025-2026 influenza vaccine
An H3N2 variant, named subclade K, continues to circulate widely during the 2025-2026 influenza season. This virus possesses a hemagglutinin (HA) protein that has eleven substitutions relative to the ...
23422
Reposted by Raiees Andrabi
Bloom lab @jbloomlab.bsky.social · 20/02/2026
We have posted data providing real-time measurement of human neutralizing antibody landscape to seasonal influenza. Data explain spread of subclades K (H3N2) & D.3.1.1 (H1N1), identify subclade K subvariants w reduced neutralization, & can inform choice of strains for next vaccine.
17637
Raiees Andrabi @raieesandrabi.bsky.social · 15/02/2026
Now peer-reviewed at @sciimmunology.bsky.social Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development | Science Immunology www.science.org/doi/10.1126/...
science.org
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody development
B cell priming is a primary bottleneck to HIV-1 V2 apex bNAb elicitation.
142
Raiees Andrabi @raieesandrabi.bsky.social · 09/07/2025
In our new study, we show that several pre-Omicron RBD bnAbs still neutralize highly mutated SARS-CoV-2 variants. Structures reveal conserved, vaccine-targetable epitopes that resist extreme antigenic drift, highlighting promising targets for pan-sarbecovirus vaccines www.cell.com/cell-reports...
cell.com
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Identifying and understanding the molecular basis of conserved spike epitopes targeted by broadly neutralizing antibodies (bnAbs) are key for developing broad coronavirus vaccine design. Song et al. r...
183
Raiees Andrabi @raieesandrabi.bsky.social · 26/06/2025
A fantastic collaborative effort with the BatistaLab (Ragon/Harvard), ShawLab(Penn) and IrvineLab (Scripps) where we show how targeted immunogen design can induce HIV broadly neutralizing antibody responses! www.biorxiv.org/content/10.1...
biorxiv.org
Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization
Current vaccine strategies to elicit broadly neutralizing antibodies (bnAbs) against HIV-1 generally propose complex, multi-boost immunization regimens. In rhesus macaques, SHIV infection has been obs...
051